• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Apricus Biosciences Inc

+ Add to Watchlist

APRI:US

1.9000 USD 0.0100 0.53%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Apricus Biosciences Inc (APRI)

Open: 1.8800 Day's Range: 1.8800 - 1.9400 Volume: 131,465
Previous Close: 1.8900 52wk Range: 1.6600 - 2.7100 1-Yr Rtn: -3.06%

Stock Chart for APRI

No chart data available.
  • APRI:US 1.9000
  • 1D
  • 1M
  • 1Y
1.8900
Interactive APRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APRI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2960
Est. EPS (USD) (12/2014) -0.2500
Est. PEG Ratio -
Market Cap (M USD) 72.39
Shares Outstanding (M) 38.10
30 Day Average Volume 153,675
Price/Book (mrq) 8.0905
Price/Sale (ttm) 12.3135
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APRI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for APRI

Apricus Biosciences Inc. is a bio-technology company. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer.

Richard W PascoeChief Executive OfficerSteve MartinSenior VP/CFO/Secretary
Edward CoxVP:Commercial Development
More Company Profile & Key Executives for APRI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil